Harlan Levine, M.D., is chief strategy officer of City of Hope, chief executive of City of Hope Medical Foundation and member of the CEO Council. In these roles, he is accountable for strategy, growth, business development, marketing, clinical informatics, product innovation and commercialization, payer strategies, the Center for International Medicine and the management of the medical group practice. He is a member of the comprehensive cancer center executive committee.
Prior to City of Hope, he served as executive vice president of Wellpoint Inc., the executive leadership team member leading the Comprehensive Health Solutions division, responsible for overseeing health and specialty management, pharmacy, and health care, retail and clinical IT strategy.
Prior to WellPoint, Dr. Levine was the national practice leader for Tower Watson’s health management consulting practice. Before that, he served in roles of increasing clinical management responsibility, including chief clinical officer of OptumHealth, a division of United Health Group, based in Minneapolis.
Dr. Levine has previously served as a member of IBM’s Watson Healthcare Board of Advisors, the board of directors of the Patient Centered Primary Care Collaborative and the Disease Management Association of America, and an advisory group for GE Ventures/Healthcare Incubations. He currently serves on the Strategic Advisory Board for Quantum Health and the Executive Advisory Council for California Lutheran University’s School of Management.
Dr. Levine is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard University, his medical degree from the University of California San Francisco, and interned at Mount Zion Hospital and Medical Center in San Francisco. He completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles.